
Taurine (500mg) + Acetylcysteine (150mg)
Active composition
+1 more active ingredient
Acetylcysteine breaks disulfide bonds in mucus, reducing its viscosity and promoting mucus clearance.
Medical applications
Jypicytin Tablet is a pharmaceutical formulation combining Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and enhance antioxidant defense mechanisms. Taurine, a sulfur-containing amino acid, plays a critical role in cardiovascular function, bile salt formation, and modulation of calcium signaling, contributing to neuroprotective and cardioprotective effects. Acetylcysteine, a precursor of glutathione, acts as a potent antioxidant and mucolytic agent, facilitating the reduction of oxidative stress and promoting the clearance of mucus in respiratory conditions. The synergistic action of Taurine and Acetylcysteine in Jypicytin Tablet aids in mitigating oxidative damage, improving cellular metabolism, and supporting detoxification pathways. This combination is particularly beneficial in managing conditions associated with oxidative stress, such as chronic respiratory diseases, hepatic disorders, and neurodegenerative conditions. Jypicytin is indicated as an adjunct therapy to improve clinical outcomes by enhancing antioxidant capacity and preserving cellular integrity. It is generally well-tolerated, with a favorable safety profile when used as directed. Healthcare professionals should consider patient-specific factors and contraindications before prescribing. Regular monitoring is advised to assess therapeutic efficacy and detect any adverse reactions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Jypicytin Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Jypicytin Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Jypicytin Tablet is safe to use in patients with kidney disease. No dose adjustment of Jypicytin Tablet is recommended.
Exercise Caution
It is not known whether Jypicytin Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Jypicytin Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Jypicytin Tablet

Taurine (500mg) + Acetylcysteine (150mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Acetylcysteine breaks disulfide bonds in mucus, reducing its viscosity and promoting mucus clearance.
Medical applications
Jypicytin Tablet is a pharmaceutical formulation combining Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and enhance antioxidant defense mechanisms. Taurine, a sulfur-containing amino acid, plays a critical role in cardiovascular function, bile salt formation, and modulation of calcium signaling, contributing to neuroprotective and cardioprotective effects. Acetylcysteine, a precursor of glutathione, acts as a potent antioxidant and mucolytic agent, facilitating the reduction of oxidative stress and promoting the clearance of mucus in respiratory conditions. The synergistic action of Taurine and Acetylcysteine in Jypicytin Tablet aids in mitigating oxidative damage, improving cellular metabolism, and supporting detoxification pathways. This combination is particularly beneficial in managing conditions associated with oxidative stress, such as chronic respiratory diseases, hepatic disorders, and neurodegenerative conditions. Jypicytin is indicated as an adjunct therapy to improve clinical outcomes by enhancing antioxidant capacity and preserving cellular integrity. It is generally well-tolerated, with a favorable safety profile when used as directed. Healthcare professionals should consider patient-specific factors and contraindications before prescribing. Regular monitoring is advised to assess therapeutic efficacy and detect any adverse reactions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Jypicytin Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Jypicytin Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Jypicytin Tablet is safe to use in patients with kidney disease. No dose adjustment of Jypicytin Tablet is recommended.
Exercise Caution
It is not known whether Jypicytin Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Jypicytin Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Jypicytin Tablet















